Senapedis W - Search Results

1

TACC3-TSC2 maintains nuclear envelope structure and controls cell division.

Gómez-Baldó L, Schmidt S, Maxwell CA, Bonifaci N, Gabaldón T, Vidalain PO, Senapedis W, Kletke A, Rosing M, Barnekow A, Rottapel R, Capellá G, Vidal M, Astrinidis A, Piekorz RP, Pujana MA. Gómez-Baldó L, et al. Among authors: senapedis w. Cell Cycle. 2010 Mar 15;9(6):1143-55. doi: 10.4161/cc.9.6.11018. Epub 2010 Mar 15. Cell Cycle. 2010. PMID: 20237422

2

Hamartin, the tuberous sclerosis complex 1 gene product, interacts with polo-like kinase 1 in a phosphorylation-dependent manner.

Astrinidis A, Senapedis W, Henske EP. Astrinidis A, et al. Among authors: senapedis w. Hum Mol Genet. 2006 Jan 15;15(2):287-97. doi: 10.1093/hmg/ddi444. Epub 2005 Dec 8. Hum Mol Genet. 2006. PMID: 16339216

3

Cell cycle-regulated phosphorylation of hamartin, the product of the tuberous sclerosis complex 1 gene, by cyclin-dependent kinase 1/cyclin B.

Astrinidis A, Senapedis W, Coleman TR, Henske EP. Astrinidis A, et al. Among authors: senapedis w. J Biol Chem. 2003 Dec 19;278(51):51372-9. doi: 10.1074/jbc.M303956200. Epub 2003 Oct 9. J Biol Chem. 2003. PMID: 14551205 Free article.

4

Expression of wild type and mutant TSC2, but not TSC1, causes an increase in the G1 fraction of the cell cycle in HEK293 cells.

Khare L, Astrinidis A, Senapedis W, Adams PD, Henske EP. Khare L, et al. Among authors: senapedis w. J Med Genet. 2002 Sep;39(9):676-80. doi: 10.1136/jmg.39.9.676. J Med Genet. 2002. PMID: 12205112 Free PMC article. No abstract available.

5

XPO1-dependent nuclear export is a druggable vulnerability in KRAS-mutant lung cancer.

Kim J, McMillan E, Kim HS, Venkateswaran N, Makkar G, Rodriguez-Canales J, Villalobos P, Neggers JE, Mendiratta S, Wei S, Landesman Y, Senapedis W, Baloglu E, Chow CB, Frink RE, Gao B, Roth M, Minna JD, Daelemans D, Wistuba II, Posner BA, Scaglioni PP, White MA. Kim J, et al. Among authors: senapedis w. Nature. 2016 Oct 6;538(7623):114-117. doi: 10.1038/nature19771. Epub 2016 Sep 28. Nature. 2016. PMID: 27680702 Free PMC article.

6

Targeting Nuclear Exporter Protein XPO1/CRM1 in Gastric Cancer.

Sexton R, Mahdi Z, Chaudhury R, Beydoun R, Aboukameel A, Khan HY, Baloglu E, Senapedis W, Landesman Y, Tesfaye A, Kim S, Philip PA, Azmi AS. Sexton R, et al. Among authors: senapedis w. Int J Mol Sci. 2019 Sep 28;20(19):4826. doi: 10.3390/ijms20194826. Int J Mol Sci. 2019. PMID: 31569391 Free PMC article.

7

Clinical translation of nuclear export inhibitors in cancer.

Senapedis WT, Baloglu E, Landesman Y. Senapedis WT, et al. Semin Cancer Biol. 2014 Aug;27:74-86. doi: 10.1016/j.semcancer.2014.04.005. Epub 2014 Apr 19. Semin Cancer Biol. 2014. PMID: 24755012 Review.

8

Therapeutic Potential of Targeting PAK Signaling.

Senapedis W, Crochiere M, Baloglu E, Landesman Y. Senapedis W, et al. Anticancer Agents Med Chem. 2016;16(1):75-88. doi: 10.2174/1871520615666150617111414. Anticancer Agents Med Chem. 2016. PMID: 26081410 Review.

9

Targeting the Nuclear Export Protein XPO1/CRM1 Reverses Epithelial to Mesenchymal Transition.

Azmi AS, Muqbil I, Wu J, Aboukameel A, Senapedis W, Baloglu E, Bollig-Fischer A, Dyson G, Kauffman M, Landesman Y, Shacham S, Philip PA, Mohammad RM. Azmi AS, et al. Among authors: senapedis w. Sci Rep. 2015 Nov 5;5:16077. doi: 10.1038/srep16077. Sci Rep. 2015. PMID: 26536918 Free PMC article.

10

XPO1 Inhibition Preferentially Disrupts the 3D Nuclear Organization of Telomeres in Tumor Cells.

Taylor-Kashton C, Lichtensztejn D, Baloglu E, Senapedis W, Shacham S, Kauffman MG, Kotb R, Mai S. Taylor-Kashton C, et al. Among authors: senapedis w. J Cell Physiol. 2016 Dec;231(12):2711-9. doi: 10.1002/jcp.25378. Epub 2016 Apr 8. J Cell Physiol. 2016. PMID: 26991404 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

49 results

Search Page